ArticleTropical medicine & international health : TM & IH2025
An Equity-Focused Systematic Analysis of Antimicrobial Resistance National Action Plans in 14 West African Countries.
Article in Tropical medicine & international health : TM & IH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An Equity-Focused Systematic Analysis of Antimicrobial Resistance National Action Plans in 14 West African Countries.Tropical medicine & international health : TM & IH · 2025Article
- Leveraging a people-centred approach to combat antimicrobial resistance in Africa.Tropical medicine and health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesAntimicrobial resistance is a growing global health threat that disproportionately affects socially and economically disadvantaged populations. National Action Plans are critical for coordinating national responses, but the extent to which they address equity remains unclear. This study assessed how antimicrobial resistance National Action Plans from 14 West African countries incorporate equity considerations.
methodsWe reviewed antimicrobial resistance National Action Plans from 14 West African countries using a four-domain equity framework: (1) recognition of equity, (2) identification of vulnerable populations, (3) inclusion of equity-oriented interventions and (4) integration of equity into governance and monitoring. We assessed whether National Action Plans acknowledged 16 high-risk groups, including people living with HIV, displaced or mobile populations, children and adolescents, older adults, people with mental health disorders, rural residents, people with chronic illnesses, people living with disabilities, pregnant women, low-income populations, healthcare workers, people with substance use disorders, incarcerated populations, indigenous or minority groups, homeless populations and migrants or seasonal workers.
resultsAll National Action Plans adopted a One Health approach, but equity was inconsistently addressed. Most did not explicitly reference equity, and none included equity-related indicators in monitoring frameworks. Healthcare workers and rural populations were the most frequently mentioned groups. Common interventions included hygiene promotion, public awareness campaigns and training of healthcare workers, but these were largely generic and rarely adapted to the specific needs of marginalised populations. Stakeholder engagement was often multisectoral but seldom ensured the participation of disadvantaged groups. Across the region, the lack of disaggregated data and tailored strategies highlights a significant equity gap.
conclusionEquity remains insufficiently integrated into antimicrobial resistance governance in West Africa. Future National Action Plans must explicitly identify at-risk populations, include equity indicators and involve affected communities in planning and oversight. Embedding equity is essential to building resilient and people-centred antimicrobial resistance strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.